Heron Therapeuti Stock Investor Sentiment

HRTX Stock  USD 1.07  0.01  0.94%   
Slightly above 56% of Heron Therapeuti's investor base is looking to short. The analysis of the overall investor sentiment regarding Heron Therapeuti suggests that many traders are alarmed. Heron Therapeuti's investing sentiment can be driven by a variety of factors including economic data, Heron Therapeuti's earnings reports, geopolitical events, and overall market trends.
  

Heron Therapeuti Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Heron Therapeuti can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a day ago at news.google.com         
Heron Therapeutics Q3 Earnings Snapshot - Marketscreener.com
Google News at Macroaxis
few days ago at bbc.co.uk         
Heron Foods Grimsby store must have security to sell alcohol
news
six days ago at thelincolnianonline.com         
Heron Therapeutics, Inc. Short Interest Down 6.0 percent in October
news
over a week ago at thelincolnianonline.com         
Heron Therapeutics Upgraded by StockNews.com to Buy Rating
news
over a week ago at thelincolnianonline.com         
Heron Therapeutics Posts Earnings Results, Meets Expectations
news
over a week ago at businesswire.com         
Heron Finance Launches Industry-Leading Personalized Private Credit Portfolio
businesswire News
over a week ago at simplywall.st         
Heron Therapeutics Third Quarter 2024 Earnings EPS Beats Expectations, Revenues Lag
Simply Wall St News at Macroaxis
over a week ago at simplywall.st         
Investors Dont See Light At End Of Heron Therapeutics, Inc.s Tunnel And Push Stock Down 30
Simply Wall St News at Macroaxis
over a week ago at insidermonkey.com         
Heron Therapeutics, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over a week ago at simplywall.st         
Why Investors Shouldnt Be Surprised By Heron Therapeutics, Inc.s 30 percent Share Price Plunge
Simply Wall St News at Macroaxis
over a week ago at gurufocus.com         
Heron Therapeutics Inc Q3 2024 Earnings Call Highlights Strategic Initiatives Drive ...
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Heron Therapeutics Reports Q3 Loss, Misses Revenue Estimates
Yahoo News
over a week ago at investing.com         
Heron Therapeuti earnings beat, revenue fell short of estimates
Investing News at Macroaxis
over a week ago at gurufocus.com         
Heron Therapeutics Inc Reports Q3 2024 Net Product Sales of 32. ...
Gurufocus Stories at Macroaxis
over a week ago at seekingalpha.com         
Heron Therapeutics GAAP EPS of -0.03 in-line, revenue of 32.81M misses by 4.12M
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Heron Therapeuti that are available to investors today. That information is available publicly through Heron media outlets and privately through word of mouth or via Heron internal channels. However, regardless of the origin, that massive amount of Heron data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Heron Therapeuti news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Heron Therapeuti relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Heron Therapeuti's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Heron Therapeuti alpha.

Heron Therapeuti Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
How to Watch Oscar Winner The Boy and the Heron at Home
09/10/2024
2
Acquisition by Lisa Peraza of 1289 shares of Heron Therapeuti subject to Rule 16b-3
10/04/2024
3
Disposition of 13797 shares by Craig Collard of Heron Therapeuti subject to Rule 16b-3
10/18/2024
4
Acquisition by Christian Waage of 83685 shares of Heron Therapeuti at 2.09 subject to Rule 16b-3
10/21/2024
5
Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors
11/04/2024
6
Unveiling Heron Therapeutics Q3 Outlook Wall Street Estimates for Key Metrics
11/07/2024
7
Heron Therapeutics Reports Q3 Loss, Misses Revenue Estimates
11/12/2024
8
Why Investors Shouldnt Be Surprised By Heron Therapeutics, Inc.s 30 percent Share Price Plunge
11/13/2024
9
Heron Finance Launches Industry-Leading Personalized Private Credit Portfolio
11/14/2024

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.